Xenetic Biosciences Announces First Quarter 2014 Financial Results and Business Update
5/21/2014 9:35:18 AM
LEXINGTON, Mass., May 21, 2014 (GLOBE NEWSWIRE) -- Xenetic Biosciences (OTCBB:XBIO), a biopharmaceutical company focused on developing next-generation biologic drugs and novel oncology therapeutics, today reported financial results for the quarter ended March 31, 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by